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一方、寺子屋形式（小人数制）の講産（薬証会）を解説し、 2ヶ月に3自から 1ヶ月に 1@J位の割合
で系統的に漢方臨床を教育する場を設け運営している。
。?
く〉原著論文。KawashimaK., Fujimura YらMakinoY叫 andKano Y.: Pharmacological Properties of 
Traditional Medicines(XXXII) Protective Effects of Hangeshashinto and the Combinations 
of its Major Constituents on Gastric Lesions in Rats. Biol. Pharm. Bull. 29: 1973・1975
2006. 
Abstract: The propective effect of Hangeshashinto(HST) and its major constituentsラbaicaline(BA),
berberine(BE), saponin丘action(GS)and glycyrrhizin(GL) on rat gastric lesion induced by ethanol was 
examined to clariちfits active ingredients and action mechanism. Oral treatment with HST at the dosees of 
125 and 250mg/kg suppressed ethanol-induced gastric lesions. The mixture ofBA,BEラGLGS(4M）ラeach
of BEラGLand GS at the dosage corresponded to HST(125mg) also suppressed the ethanol-induced gastric 
lesion in ratsラbutBAdid not. Treatment of rthenol augmented the activity of myeloperoxidase(MPO) in 
the stomachラwhichwas significantly suppressed by the administration of HSτ，BE, GL and GS. These 
results suggest that the protective effect of HST on ethanol-induced gastric lesion was depended on 
BE,GL and GS, by, in part, the reduction ofMPO activity in stomach. 
2) Kong L., Yuan D., Chen Y., Tin J., Makino T., Uno T吋 ZhangS., and Kano Y.: Quanlity 
Evaluation of Echinaceae Species Cultivated in China. Asean J. Trad. Chin.きまed.,1: 25-30 
2006. 
Abstract: For the司ualityevaluation of the raw materials ofEchinaceae species in Chinaラthecontents of 
5 maker compounds in 31 samples botanically identified as E.purpurea (L.)MOENCH, E. angustifolia 
DC. Or E . pallida(NUTT.)NUTT. were determined by HPLC; these were 3 caffeoyl co可ugates,i.e. 
eichoric acid, echinacoside and chlorogenic acidラandtwo stereo-isomers of alkamideラi.e.dodeca之Eラ
4Eラ8Z,1 OE/Z-tetranoic acid isobutylamide. The samples 合omthree Echinaceae species showed a great 
difference in the chemical composition of the caffeoyl phenols. The components of 5 maker components 
in 7 samples of E.purpurea were lower in comparison with those企omGerτnan or Australian sources 
descriもedin previous reports. A detailed analysis on the distribution of the 5 maker compounds in 
different parts of E手UI予ureaas well as their variations during flowering_demonstrated that the capi旬la
accumulated high concentrations of the caffeoyl phenols and alkamidesラandthat the content of caffeoyl 
phenols varied markedly with the different seasons. These results may be helpful not only for the 
standardization of the raw materials of E. purpurea as well as other two E. species from Chinese markets, 
but also in helping with their selection and cultivation in China. 
3) Bing W.ラDanY., Bin M., Yuan-yuan X., Jun Y., and Kano Y.: Studies on chemical 
constituents of the leaves ofUncaria rhynchophylla (Miq.) Jacks. Chinese J. of Med. Chem. 
16:369・372,2006. 
Abstract: For the qualiちfevaluation of the raw materials of Echinacea species cultivated in Chinaラthe
contents of 5 marker compounds in 31 samples botanically identified as E.purpurea (L.) MOENCHヲ
E.angustifolia DC . or E.pallida (NUTτ.） NじTT.were determined by HPLC; these were 3 caffeoyl 
conjugates, i.e.cichoric acide, echinacoside and chlorogenic acidラandtwo stereo-isomers of alkamide, 
i.e.dodeca-2Eラ4E,8Z,10E/Z-retraenoicacid isobutylamide. The samples合omthree Echinacea species 
showed a great difference in the chemical composition of the caffeoyl phenols. The contents of 5 marker 
compounds in 7 sample of E.purpurea were lower in comparison with those from German or Australian 
sources described in previous reports. A detailed analysis on the dis佐治utionof the 5 marker compounds 
in different parts of E.purpurea as well as their variations during flowering demonstrated that the capitula 
accumulated high concentrations of the caffeoyl phenols and alkamides, and that the content of caffeoyl 
phenols varied markedly with the different seasons. These results may be helpful not for the 
standardization of the raw materials of E.purpurea as well as other two E.species 企omChinese marketsラ











2) 鹿野義弘：漢方薬物の薬学的諸問題．礼続漢方研究会， 2006, 5/16，札幌．
3) 鹿野義弘：私の研究．県薬事研究会， 2006,5123，富山．
4) 鹿野義弘：研究紹介．研究所セミナー，研究所大会議室， 2006, 5123，富山．
5) 麗野義弘：：開発に関する基本方針，富山オリジナノレブランド研究会， 2006,7/5，富山．
6) 麗野義弘：：四獣神と漢方．富山漢方会講演会， 2006,7/7，富山．
7) 鹿野義弘：水の病慈と漢方治療．函館東洋室学研究会， 2006, 7/8，函館．
8) 鹿野義弘：健康とは．室薬品配置販売者大会， 2006, 8/18，富山．
9) 鹿野義弘：貯の病態と漢方治療．中日本漢方研究会， 2006, 8/19，名古屋．
10) 毘野義弘：漢方薬に期待される効果とは．和漢医薬学総合研究所夏期セミナー， 2006,
8/29-31，富山．
11) 麗野義弘：肺の病慈と漢方治療．函舘東洋匿学研究会， 2006, 919，函館．
12) 鹿野義弘：牌胃の病態と漢方治療－1. 中日本漢方研究会， 2006, 10/21，名古屋．
13) 鹿野義弘：製品開発の方針．薬事講演会， 2006, 11/2，富山．
14) 鹿野義弘：漢方医学総論－1. 第1田漢方寺子墨・薬証会， 2006, 11/8，富山．
15) 鹿野義弘：漢方医薬学総論．石川漢方研究会， 2006, 11/18，金沢．
16) 麗野義弘：漢方医学総論，2.第2巨漢方寺子差・薬託会， 2006, 11/30，富山．
17) 麗野義弘：：牌胃の病態と漢方治療－2. 中日本漢方研究会， 2006, 12/16，名主屋．
18) 鹿野義弘：漢方医学総論－2.第2田漢方寺子崖・薬託会， 2006, 12/21，富山．
以上の也、富山県製薬企業での開発会議に参加 cs時、回数、内容などは非公開）
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